false
OasisLMS
zh-CN,zh-TW,en,fr,de,hi,ja,ko,pt,es
Catalog
EndoBytes: Patient-Centered Approach to Hypercorti ...
Treatment and Long-Term Care of Patients with Hype ...
Treatment and Long-Term Care of Patients with Hypercortisolism (Cushing Syndrome and MACS)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This module reviews treatment and long-term care for hypercortisolism, including Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS). Surgery is first-line for cortisol excess, but many require adjunctive therapies like steroidogenesis inhibitors, pituitary agents, or glucocorticoid receptor antagonists. Barriers include cost, side effects, and access disparities. Long-term care must address persistent cardiometabolic, bone, and quality-of-life issues via structured follow-up. A personalized, multimodal approach involving endocrinologists, surgeons, radiologists, and other specialists is crucial. Multidisciplinary teams at specialized centers improve outcomes, ensure comprehensive management, and optimize survivorship through integrated patient-centered care.
Keywords
hypercortisolism treatment
Cushing Syndrome
Mild Autonomous Cortisol Secretion
steroidogenesis inhibitors
multidisciplinary care
×